<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: gene products</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study IDs key protein for cell death, offers way to kill cancer cells by forcing them into programmed-death pathway</title>
   	 <description>When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their DNA.</description>
     <link>http://medicalxpress.com/news/2013-05-ids-key-protein-cell-death.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 14 May 2013 06:27:15 EST</pubDate>
	 <guid isPermaLink="false">news287731615</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/studyidskeyp.jpg" width="90" height="90" />
</item>
<item>
     <title>Analysing meningitis genes to identify new treatments</title>
   	 <description>Scientists at the University of Liverpool are working to identify genes involved in the development of bacterial meningitis to support the search for new vaccine candidates.</description>
     <link>http://medicalxpress.com/news/2013-04-analysing-meningitis-genes-treatments.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 19 Apr 2013 07:56:02 EST</pubDate>
	 <guid isPermaLink="false">news285576955</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/analysingmen.jpg" width="90" height="90" />
</item>
<item>
     <title>Excess protein linked to development of Parkinson's disease</title>
   	 <description>Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells' center, with the potential consequence of progressive degeneration and eventual cell death.</description>
     <link>http://medicalxpress.com/news/2013-02-excess-protein-linked-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Thu, 07 Feb 2013 14:52:55 EST</pubDate>
	 <guid isPermaLink="false">news279471152</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/excessprotei.jpg" width="90" height="90" />
</item>
<item>
     <title>New biomarker may help in detecting gliomas</title>
   	 <description>Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.</description>
     <link>http://medicalxpress.com/news/2013-01-biomarker-gliomas.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 16 Jan 2013 13:01:20 EST</pubDate>
	 <guid isPermaLink="false">news277563674</guid>
	 
</item>
<item>
     <title>Binding sites for LIN28 protein found in thousands of human genes</title>
   	 <description>A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases. According to the researchers, their study – published in the September 6 online issue of Molecular Cell – will change how scientists view this protein and its impact on human disease.</description>
     <link>http://medicalxpress.com/news/2012-09-sites-lin28-protein-thousands-human.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 04 Sep 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news265962584</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/bindingsites.jpg" width="90" height="92" />
</item>
<item>
     <title>Opioid receptors as a drug target for stopping obesity</title>
   	 <description>Imagine eating all of the sugar and fat that you want without gaining a pound. Thanks to new research published in The FASEB Journal, the day may come when this is not too far from reality. That's because researchers from the United States and Europe have found that blocking one of three opioid receptors in your body could turn your penchant for sweets and fried treats into a weight loss strategy that actually works. By blocking the delta opioid receptor, or DOR, mice reduced their body weight despite being fed a diet high in fat and sugar. The scientists believe that the deletion of the DOR gene in mice stimulated the expression of other genes in brown adipose tissue that promoted thermogenesis.</description>
     <link>http://medicalxpress.com/news/2012-07-opioid-receptors-drug-obesity.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Tue, 31 Jul 2012 10:50:33 EST</pubDate>
	 <guid isPermaLink="false">news262950619</guid>
	 
</item>
<item>
     <title>Abnormal gene product associated with prostate cancer generated by unusual mechanism</title>
   	 <description>Researchers have identified a potential new pathway in prostate cancer cells by which cancer-driving gene products can be generated, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-06-abnormal-gene-product-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 19 Jun 2012 10:51:59 EST</pubDate>
	 <guid isPermaLink="false">news259321786</guid>
	 
</item>


</channel>
</rss>
